Suchergebnisse - "Fichna, Jakub"

PubPharm (32)

1

The role of bidirectional communication between the adipokines and the endogenous opioid system in an experimental mouse model of colitis-associated colorectal cancer

enthalten in: Pharmacological reports : PR | 2024

von Szymaszkiewicz, A. | Mierzejewski, M. | Januszkiewicz, E. | +7

2

The role of kappa opioid receptors in immune system - An overview

enthalten in: European journal of pharmacology | 2022

von Szczepaniak, A. | Machelak, W. | Fichna, J. | +1

3

The Involvement of the Endogenous Opioid System in the Gastrointestinal Aging in Mice and Humans

enthalten in: International journal of molecular sciences | 2022

von Szymaszkiewicz, A. | Talar, M. | Włodarczyk, J. | +7

4

Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders

enthalten in: American journal of physiology. Gastrointestinal and liver physiology | 2022

von DiCello, J. | Carbone, S. | Saito, A. | +12

5

Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract : proof of concept

enthalten in: Pharmacological reports : PR | 2021

von Szymaszkiewicz, A. | Świerczyński, M. | Talar, M. | +4

6

New insights into molecular pathways in colorectal cancer : Adiponectin, interleukin-6 and opioid signaling

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2021

von Świerczyński, M. | Szymaszkiewicz, A. | Fichna, J. | +1

7

Opioids in Cancer Development, Progression and Metastasis : Focus on Colorectal Cancer

enthalten in: Current treatment options in oncology | 2020

von Szczepaniak, A. | Fichna, J. | Zielińska, M.

8

Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2018

von Piekielna-Ciesielska, J. | Mollica, A. | Pieretti, S. | +5

9

Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome

enthalten in: Pharmacological reports : PR | 2017

von Zielińska, M. | Jarmuż, A. | Wasilewski, A. | +3

10

Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

enthalten in: Pharmacological reports : PR | 2016

von Zielińska, M. | Jarmuż, A. | Sałaga, M. | +2